Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

EPHB3

RBC: EPHB3 · Substrate: pEY · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib98.50.70
Ponatinib97.90.53
Nilotinib89.90.77
Repotrectinib86.20.61
Bosutinib84.00.55
Ripretinib64.40.67
Tivozanib45.10.67
Cabozantinib36.80.75
Erdafitinib21.30.74
Gilteritinib13.30.51
Nintedanib13.00.61
Lorlatinib11.80.69
Crizotinib10.90.58
Neratinib10.40.60
Capmatinib9.40.58

Known variants

No variants catalogued.
Open in new tab